Dexcom announced that the FDA has expanded use of Dexcom G4 Platinum (Pediatric), a continuous glucose monitoring (CGM) device, for children ages 2–17 years with diabetes. Dexcom G4 Platinum (Pediatric) is already approved for adults ages >18 years.

RELATED: Endocrine Disorders Resource Center

The Dexcom G4 Platinum monitors glucose levels continuously for 7 days using wireless technology, which allows users to view their glucose levels as needed. The system allows patients with diabetes to program personalized information, such as glucose targets and alerts. In addition, it has an alarm feature to alert the user of dangerously high or low glucose levels.

For children in the 2–6 years age range, Dexcom G4 Platinum (Pediatric) is the only device that offers an alternate sensor wear site on the upper buttocks for extra flexibility.

For more information call (888) 738-3646 or visit